Comparison of the Medication Effects between Milnacipran and Pregabalin in Fibromyalgia Syndrome Using a Functional MRI: a Follow-up Study.
10.13104/jksmrm.2014.18.4.341
- Author:
Min Jae KANG
1
;
Chi Woong MUN
;
Young Ho LEE
;
Seong Ho KIM
Author Information
1. Department of Health Science and Technology, Inje University, Gyeongnam, Korea.
- Publication Type:Original Article
- Keywords:
fMRI;
BOLD signal;
Fibromyalgia syndrome;
Milnacipran;
Pregabalin
- MeSH:
Antidepressive Agents;
Diagnosis;
Fatigue;
Fibromyalgia*;
Follow-Up Studies*;
Humans;
Magnetic Resonance Imaging*;
Prostaglandins B;
Thalamus;
Pregabalin
- From:Journal of the Korean Society of Magnetic Resonance in Medicine
2014;18(4):341-351
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: In this study, the medication effects of Milnacipran and Pregabalin, as well known as fibromyalgia treatment medicine, in fibromyalgia syndrome patients were compared through the change of BOLD signal in pain related functional MRI. MATERIALS AND METHODS: Twenty fibromyalgia syndrome patients were enrolled in this study and they were separated into two groups according to the treatment medicine: 10 Milnacipran (MLN) treatment group and 7 Pregabalin (PGB) treatment group. For accurate diagnosis, all patients underwent several clinical tests. Pre-treated and post-treated fMRI image with block-designed pressure-pain stimulation for each group were obtained to conduct the statistical analysis of paired t-test and two sample t-test. All statistical significant level was less than 0.05. RESULTS: In clinical tests, the clinical scores of the two groups were not significantly different at pre-treatment stage. But, PGB treatment group had lower Widespread Pain Index (WPI) and Brief Fatigue Inventory (BFI) score than those of MLN treatment group at post-treatment stage. In functional image analysis, BOLD signal of PGB treatment group was higher BOLD signal at several regions including anterior cingulate and insula than MLN treatment group at post-treatment stage. Also, paired t-test values of the BOLD signal in MLN group decreased in several regions including insula and thalamus as known as 'pain network'. In contrast, size and number of regions in which the BOLD signal decreased in PGB treatment group were smaller than those of MLN treatment group. CONCLUSION: This study showed that MLN group and PGB group have different medication effects. It is not surprising that MLN and PGB have not the same therapeutic effects since these two drugs have different medicinal mechanisms such as antidepressants and anti-seizure medication, respectively, and different detailed target of fibromyalgia syndrome treatment. Therefore, it is difficult to say which medicine will work better in this study.
